People

Ann Boija

Dewpoint chief scientific officer leading condensate-based research across oncology, neurology, cardiology and metabolic disease. Her work studies gene control, transcription factor phase separation and drug partitioning into condensates. Holds a Stockholm University biology PhD and trained at the Whitehead Institute.

Roles

Dewpoint Therapeutics

Chief Scientific Officer

Current